Pubdate: Sat, 30 Mar 2002 Source: New Scientist (UK) Page: 34-37 Copyright: New Scientist, RBI Limited 2002 Contact: http://www.newscientist.com/ Details: http://www.mapinc.org/media/294 Author: Clare Wilson Bookmark: http://www.mapinc.org/heroin.htm (Heroin) http://www.mapinc.org/find?131 (Heroin Maintenance) http://www.mapinc.org/find?136 (Methadone) FIXED UP When nothing else works, heroin addicts should be prescribed the drug they crave, says Clare Wilson PAY A visit to William Shanahan's clinic in central London and you may see some strange goings-on. He hands out heroin to junkies. Shanahan is one of a small number of doctors in Britain who hold a licence to prescribe heroin to State-registered addicts. In his experience it's the best way to deal with the really tough cases-those hardest of hard-core addicts who repeatedly relapse after conventional treatment. Elsewhere, too, doctors are experimenting with heroin as a treatment for heroin addiction. Switzerland currently doles out heroin to more than 1000 addicts. Germany has allowed the practice on an experimental basis. Denmark, Spain, Australia and Canada are considering trying it. And the Netherlands has just completed two big clinical trials comparing heroin with the current therapy of choice, methadone. At the moment such programmes are small scale or experimental. But they won't stay that way. The Netherlands government, for example, intends to make heroin prescription a central plank of its drug policy. Even in Britain, traditionally conservative on drug issues, heroin prescription is moving up the political agenda. MPs on the Home Affairs Select Committee are putting the finishing touches to a report on drug policy. It's due out in the next few weeks, and insiders say it's likely to recommend wider use of heroin. So why the groundswell of enthusiasm for heroin prescription? The fact is, existing treatments for cleaning up heroin addicts aren't good enough. They leave a persistent core of junkies who simply cannot kick the habit. There's an urgent need for alternative therapies to help these people, and heroin prescription seems to fit the bill: recent research suggests that it helps these addicts stay healthy and cuts crime. The reason people descend into heroin addiction in the first place is that the drug makes them feel good. From the moment it enters your veins, you experience a warm rush of pleasure that quickly takes you over until you don't care about anything else. "You're wrapped in cotton wool, and you haven't got a care in the world," says former heroin addict Andy King, now a drug counsellor in London. Your brain turns the heroin into morphine, which stimulates the receptors for endorphins--natural chemical messengers that damp down pain signals and lift mood. Heroin is so good at mimicking endorphins that emergency rooms in Britain and a few other countries dispense heroin to accident victims as a painkiller. But the brain gets accustomed to heroin all too easily, so regular users start to need ever larger doses to achieve the same effect. Eventually their neurons only function normally in the presence of the drug. After only a few weeks on heroin, users are prone to severe withdrawal symptoms-nausea, stomach cramps, muscle aches. These lead to an almost irresistible urge for more heroin. Most addicts need two or more fixes a day. A majority of heroin addicts suffer serious health problems. The main ones come not from the drug itself but from the unhygienic conditions they take it in. Sharing syringes spreads HIV and hepatitis, and dirty needles cause abscesses and blood or heart valve infections. Some batches of heroin have been contaminated with potentially deadly bacteria. The drug can also be dangerous in its own right. Users have no reliable way to test the concentration of a batch, and so occasionally overdose by accident. The black market nature of the heroin trade also makes it a major social ill. A typical habit costs about UKP 160 a day, which helps explain why users find themselves drifting into theft and prostitution. A recent British study into drug use and crime found that 3 out of 10 people who were arrested by the police were opiate users. And while that's not proof of a link between crime and drugs, it's highly suggestive of one. At present there are two main escape routes from heroin addiction back into mainstream society. Addicts can either volunteer for treatment, or be forced into it by the courts. The standard treatment is methadone, in the form of a sugary green drink. Methadone hits the same brain receptors as heroin but is much sloweracting. That means it staves off withdrawal symptoms but doesn't produce much of a high. Users only need a once-daily dosehighly convenient, when addicts must take it under the doctor's nose. And the lack of a kick also makes methadone socially acceptable, as no once can suggest doctors are enabling their patents to get high. The idea is that methadone frees addicts from the worry of finding their next fix, so they have a chance to sort out their lives. The first step is to get stabilised on a fixed daily dose. Then when they're ready, addicts can be weaned off till they're clean. But methadone programmes aren't popular with heroin addicts, partly because the drug doesn't give them the high they crave. Many patients top up their dose with street heroin, a practice that often gets them kicked off the programmes. Then there's the methadone itself. The sugary mixture it comes in makes it too sticky to be injected, so long-term users often have bad teeth, and diabetics have difficulty using it. Worse, methadone is addictive, and withdrawal-when it is eventually faced-is more protracted than with heroin. And it's easier to overdose on methadone than on heroin (New Scientist, 1 October 1994, p 36). Many users complain that the health system has got them addicted to a drug that's worse than heroin. "It's far worse coming off methadone than heroin," recalls King. "It feels like it gets into your bones. The worst is over within about five days, but it took me about six weeks to feel like I had a night's sleep. I came off drugs despite methadone, not because of it." Another reason some addicts fail on methadone is that they crave the physical sensation of sticking a needle into themselves. lan Guy, a Middlesborough doctor specialising in drug addiction who has applied for a licence to dispense heroin, says one of his patients is so desperate to inject that after swallowing his oral methadone under supervision, he secretly spits the dregs into a container to draw up into a syringe. Estimates vary as to how many addicts flunk methadone programmes, but it's not unusual for half to three-quarters of patients to test positive when their urine is analysed for heroin. "People who cannot or will not settle on oral methadone alone will carry on injecting whether you like it or not," says Shanahan, who works as a psychiatrist at the Chelsea and Westminster substance abuse service in London. These problems have prompted a search for alternatives. Some doctors, for example, are experimenting with injectable forms of methadone, which many users feel satisfy their cravings better than drinking it. There's also a new drug on the market, Subutex (see "A new cure?", p 37). The most radical alternative is to give addicts heroin itself. British doctors have been allowed to do so since 1926, though the vast majority choose not to. The first country to try it systematically was Switzerland. It has pioneered experimental clinics where registered addicts can get carefully monitored doses of heroin, which they take under medical supervision. There are now over a thousand addicts in these programmes, usually getting several fixes a day. About a third of them use oral methadone as well to stave off withdrawal while their clinic is closed overnight. Research shows that the number of patients who admitted being involved in crime fell from 70 per cent when they started the scheme to 10 per cent after 18 months. Jurgen Rehm, director of Zurich Addiction Research Institute, who carried out the study, says he now considers heroin prescription an essential treatment option. "These are people who repeatedly fail on methadone programmes," he says. "If they're not helped it costs us in terms of criminality and their health problems." The Swiss heroin trials attracted the attention of addiction specialists elsewhere. But one frequent criticism is that they were not randomised, controlled trials-the only credible approach to testing a new medical intervention of this kind, where there's no of disguising who's getting which drug. In a randomised trial, patients taking a new treatment are compared with a similar group taking the old one and patients have no choice of which treatment they get. But two large, randomised trials of heroin prescription have now been done. Started by Dutch doctors in 1998 at the request of their government, they involved a total of 549 addicts who had repeatedly failed methadone programmes. Around half got heroin plus methadone, and the rest just methadone. The trials ended last year and the results look promising. In their final report, published in February, the Dutch team said that after 6 or 12 months, about half of the heroin-plus-methadone group were both healthier and committing less crime than when they started on the trial. This compared with 25 per cent of those on methadone alone. What's more, when those on heroin plus methadone had their heroin stopped, 80 per cent of them lost all their health gains within two months. Jan van Ree, professor of psychopharmacology at Utrecht University, who led the research, says giving addicts free heroin means "they don't have to decide when they get out of bed in the morning what they're going to steal today". Not all drug addiction specialists, though, believe this is the right thing to do. Clare Gerada is a doctor who runs a methadone clinic in a rundown area of London. She's doubtful you can repeat the success of a wellfunded clinical trial in tough, front-line services such as the one she runs. She says: "Once you move out of research and into the real world, there's less counselling and support, and the heroin starts getting sold on." The main problem is that community clinics lack the resources to stay open in the evenings and at weekends, so would face pressure to give out heroin for later use. And that risks creating a black market in pharmaceutical-grade heroin. The alternative is to give patents methadone to see them through the night, which they might be tempted to supplement with street heroin. Another downside is that if heroin prescription becomes more widely available, some addicts may not even try to give up. As a safeguard supporters agree that it should only be offered to long-term addicts who have repeatedly tried and failed on methadone programmes. The biggest obstacle, though, is political. To some, it's simply not acceptable to supply addicts with heroin. Doing so is tantamount to legalising drugs. The position might be illogical-after all, it's okay to give junkies a different addictive drug, methadone, and the long-term objective remains to clean them up. But it's is a powerful force, especially in the US. A handful of doctors there argue in favour of trials but it's a losing battle, even within their own profession. "Many doctors here are ignorant of addiction," says Ernest Drucker, a professor of epidemiology and social medicine at the Albert Einstein College of Medicine in New York who is trying to set up a trial. "They are even hostile to methadone." There are signs, however, that politicians in Europe are willing to take on the challenge. Earlier this month the Dutch government formally incorporated heroin prescription into official drugs policy. And in Britain, a Home Affairs Select Committee inquiry into drugs policy has specifically investigated heroin prescription. The report is still confidential, but one insider told New Scientist it will recommend clinical trials of heroin versus methadone. And the new government body charged with improving drug services, the National Treatment Agency, is drawing up guidelines on heroin prescription, due out by the end of the year. The agency's chief executive, Paul Hayes, says the committee wants to examine whether heroin prescription should be used more widely. At present 400 or so addicts receive heroin on the National Health Service. The agency thinks there may be a case for increasing that number. As doctor lan Guy says: "We have to ask ourselves what we want. 1 want healthier patients who get their life stabilised. They're going to make damn sure they get their heroin from somewhere. Rather than some illegal pusher, I'd prefer if it were me." [SIDEBAR] A New Cure? Prescribing heroin isn't the only alternative to methadone maintenance. There's a new drug too: buprenorphine, which is sold by American pharmaceuticals company Schering-Plough as Subutex. Like methadone, Subutex latches onto endorphin receptors in the brain and so staves off heroin withdrawal symptoms. But its pharmacology is subtly different-it binds to the receptor more tightly, yet stimulates it less powerfullyso has some advantages as a therapy. First, it's harder to overdose on Subutex because you need a much bigger dose. Secondly, it binds so tightly to the receptor that it blocks morphine molecules from attaching. So addicts who succumb to temptation and take heroin on top of their Subutex don't get high. Subutex has been available in France since 1996 and other European countries, including Britain, are starting to experiment with it (see Map, right). Many addicts prefer Subutex to methadone. But not all feel it works for them principally because, as with methadone, they still crave the high, So Subutex isn't a miracle cure for heroin addiction. There is also a practical problem. The drug comes in a tablet that must be dissolved under the tongue for about 10 minutes. Some addicts pretend that the tablet is dissolving but hold it to the side of their mouth, to spit out later. They may then crush and inject it, which gives a better high, or sell it on. A new formulation may soon be launched that has no effect when injected. - --- MAP posted-by: Richard Lake